Asian trends in prostate cancer hormone therapy.
The first Conference on Asian Trends in Prostate Cancer Hormone Therapy was held in September 2001 to serve as a forum for Asian urologists to compare data on prostate cancer and discuss issues regarding the use of hormone therapy. The conference revealed that due to various cultural and philosophical factors, differences exist in prostate cancer management among the Asian countries. In addition, a lack of databases on hormone therapy was exposed in some countries. It was noted that many decisions in the treatment of prostate cancer are influenced by the strategies adopted in Western countries, and that attempts to formulate uniform guidelines for the Asian region have hitherto been unsuccessful. The main findings of the conference are reported in this review.
Akaza
Hideyuki
H
Dept. of Urology, University of Tsukuba, Ibaraki 305-8576, Japan. akazah@md.tsukuba.ac.jp
Naito
Seiji
S
Cheng
Christopher
C
Kaisary
Amir
A
Soebadi
Doddy M
DM
Umbas
Rainy
R
Esuvaranathan
Kesavan
K
Gu
Fang-Liu
FL
Zhou
Liqun
L
Hong
Sung-Joon
SJ
Kim
Wun-Jae
WJ
Lee
Sang Eun
SE
Rim
Joung-Sik
JS
Song
Jae Mann
JM
Yoon
Jin Han
JH
Chang
Shu-Jen
SJ
Huang
Chun-Hsiung
CH
Yang
Chi-Rei
CR
Hirao
Yoshihiko
Y
Murai
Masaru
M
Tsukamoto
Taiji
T
Usami
Michiyuki
M
D000726:Androgen Antagonists / Q000627:therapeutic use*; D001208:Asia / Q000453:epidemiology; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008017:Life Expectancy; D008297:Male; D008495:Medical Oncology / Q000639:trends; D009313:National Health Programs; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D015996:Survival Rate
D000726:Androgen Antagonists; D004967:Estrogens